Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
申请人:Feenstra W. Roelof
公开号:US20060122189A1
公开(公告)日:2006-06-08
The invention relates to a group of novel phenylpiperazine derivatives with a dual mode of action: serotonin reuptake inhibition and partial agonism on dopamine-D
2
receptors. The invention also relates to the use of a compound disclosed herein for the manufacture of a medicament giving a beneficial effect.
The compounds have the general formula (1):
wherein the symbols have the meanings given in the specification. and tautomers, stereoisomers and N-oxides thereof, as well as pharmacologically acceptable salts, hydrates and solvates of said compounds of formula (1) and its tautomers, stereoisomers and N-oxides.
A novel Cu(OAc)2-catalysed direct C–H bond oxidative acetoxylation and iodination of indoles using PhI(OAc)2 as a terminal oxidant is reported. Adopting this method, a series of 3-iodoindoles and indol-3-ylacetates were obtained in nearly 1:1 ratio yield.